XBI

SPDR® S&P Biotech ETF

• The Wall Street Journal·3d ago

  Drugmakers Spared Worst-Case Drug Pricing Scenario for Now

• Benzinga·05/07 13:56

  Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation

• Benzinga·05/06 17:53

  'FDA Names Vinay Prasad as New Head of Vaccines, Biologics'- Bloomberg Law

• The Wall Street Journal·03/31 15:05

  Heard on the Street: Biotech Investors Rush for the Exits After FDA Official Resigns

• Benzinga·03/31 13:45

  Moderna, Novavax Shares Are Tumbling Monday: What's Going On?

• Benzinga·02/24 10:07

  NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst

• Benzinga·02/19 16:59

  Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports

• The Wall Street Journal·01/20 12:00

  Beaten Down Under Biden, Big Pharma Hopes for New Chapter Under Trump -- Heard on the Street

• Benzinga·01/17 15:35

  'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds

• Benzinga·01/08 17:54

  Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

• Benzinga·12/18/2024 15:40

  20 ETFs Primed For Unusually Big Swings On Fed Meeting Days

• Benzinga·11/18/2024 19:26

  A Must See Chart For Prudent Investors, Trump To Help Tesla Dominate, Nvidia Heat Problem

• Barron‘s·09/26/2024 21:16

  Healthcare Venture Investors Ante Up. Public Markets Remain Cool.

• Benzinga·07/01/2024 17:38

  Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows

• Benzinga·06/12/2024 14:09

  Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React